Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results from a candidate that could be a game changer in this area of high demand.

They are large molecule drugs, so complex in structure and must be ... manner as these market-leading products. Novo Nordisk offers a pill version of semaglutide, called Rybelsus, for type 2 ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Obesity drug developers Verve Therapeutics (VERV), Structure Therapeutics ... Wegovy is going nowhere. Moreover, Novo Nordisk's (NVO) oral semaglutide (approved as Rybelsus for diabetes) could ...

Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it ...

SkinSpirit, the premier destination for medical aesthetics and leader in Botox and dermal fillers in the nation, is proud to announce that its Chief Medical Officer, Dr. Sachin Shridharani, has been ...